Efficacy and Safety of Modified Duhuo Jisheng Decoction in the Treatment of Lumbar Disc Herniation: A Systematic Review and Meta-Analysis

Zhencheng Xiong; Ping Yi; Liubo Zhang; Haoning Ma; Wenhao Li; Mingsheng Tan

doi:10.1155/2020/2381462

Efficacy and Safety of Modified Duhuo Jisheng Decoction in the Treatment of Lumbar Disc Herniation: A Systematic Review and Meta-Analysis

Evid Based Complement Alternat Med. 2020 Jul 4:2020:2381462. doi: 10.1155/2020/2381462. eCollection 2020.

Authors

Zhencheng Xiong^{1

2}, Ping Yi², Liubo Zhang^{2

3}, Haoning Ma², Wenhao Li^{2

3}, Mingsheng Tan^{1

2

3}

Affiliations

¹ Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
² Department of Spine Surgery, China-Japan Friendship Hospital, Beijing, China.
³ Beijing University of Chinese Medicine, Beijing, China.

Abstract

Objective: Lumbar disc herniation (LDH) is based on the degenerative changes of the intervertebral disc. Many drugs are used to treat and prevent LDH, including Western medicine and Chinese medicine. Duhuo Jisheng Decoction (DHJSD) is one of the most classic Chinese medicine prescriptions. The purpose of our meta-analysis is to evaluate the efficacy and safety of modified DHJSD in the treatment of LDH.

Methods: We searched multiple databases including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI) databases, Wanfang Database, and Chinese Scientific Journal Database (VIP) to identify studies that met the inclusion criteria. This meta-analysis was registered at INPLASY with reference number ID: INPLASY202060053.

Results: Fourteen randomized controlled trials (RCTs) were identified, including 1560 patients. This meta-analysis showed that the total effective rate and cure rate of modified DHJSD are higher than those of diclofenac sodium enteric-coated tablets (total effective rate: RR = 1.18, 95% CI: 1.12 to 1.25, P < 0.0001, I ² = 0%; cure rate: RR = 1.60, 95% CI: 1.30 to 1.97, P < 0.00001, I ² = 2%), diclofenac sodium enteric-coated tablets plus ibuprofen and indomethacin (total effective rate: RR = 1.23, 95% CI: 1.11 to 1.37, P=0.0001, I ² = 0%; cure rate: RR = 1.58, 95% CI: 1.22 to 2.04, P=0.0005, I ² = 0%), and diclofenac sodium sustained-release capsule (total effective rate: RR = 1.49, 95% CI: 1.27 to 1.74, P < 0.00001, I ² = 0%; cure rate: RR = 10.07, 95% CI: 3.29 to 30.88, P < 0.00001, I ² = 5%). Modified DHJSD was also better than Western medicine (MD = -1.56, 95% CI: -2.42 to -0.70, P=0.0004, I ² = 74%) in terms of visual analogue scale (VAS) scores. Three RCTs showed no adverse events in the modified DHJSD group, but adverse events existed in the Western medicine group.

Conclusion: This meta-analysis showed that modified DHJSD had a more favorable effect on the treatment of LDH than Western medicine, and there were no obvious adverse events. More high-quality RCTs are needed to complement existing conclusions.